0.5139
Veru Inc (VERU) 最新ニュース
Veru signals Q3 2025 regulatory clarity for enobosarm Phase 3 trial - MSN
Barclays PLC Acquires 21,738 Shares of Veru Inc. (NASDAQ:VERU) - Defense World
Veru Inc. (NASDAQ:VERU) Stake Raised by Wells Fargo & Company MN - Defense World
Veru (NASDAQ:VERU) Issues Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Veru Inc. (NASDAQ:VERU) Q2 2025 Earnings Call Transcript - Insider Monkey
Veru Inc. Reports Progress in Clinical Trials and Financials - TipRanks
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... - Yahoo Finance
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... By GuruFocus - Investing.com Canada
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial Challenges - GuruFocus
Earnings call transcript: Veru Inc. beats Q2 2025 EPS forecast, stock rises - Investing.com India
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress - GlobeNewswire
Veru Q2 2025 Earnings Call Transcript - MarketBeat
Veru Inc. (VERU) Advances Obesity Program with Promising Trial Results - GuruFocus
VERU INC. SEC 10-Q Report - TradingView
Veru Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Veru Participates in a Virtual Investor KOL Connect Segment | VERU Stock News - GuruFocus
JTC Team Hosts Virtual Investor “KOL Connect” Segment to Discuss Veru Inc.’s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Sacramento Bee
JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Mid Florida Newspapers
Veru Participates in a Virtual Investor KOL Connect Segment - GlobeNewswire
2 Beaten-Down Stocks That Are Great Buys on the Dip - The Globe and Mail
Veru Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
Veru Inc (VERU) Reports Q2 Fiscal 2025 EPS of -$0.05, Beating Estimates of -$0.06; Revenue Focus Remains on Clinical Progress - GuruFocus
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress | VERU Stock News - GuruFocus
Veru Inc (VERU) Q2 2025 Earnings Report Preview: What To Look For - GuruFocus
Envestnet Asset Management Inc. Buys 75,997 Shares of Veru Inc. (NASDAQ:VERU) - Defense World
Veru (VERU) Projected to Post Earnings on Thursday - MarketBeat
Financial Snapshot: Analyzing Veru Inc (VERU)’s Key Ratio Metrics - DWinneX
Veru Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Has $166,000 Stock Holdings in Veru Inc. (NASDAQ:VERU) - Defense World
Adage Capital Partners GP L.L.C. Sells 5,561,111 Shares of Veru Inc. (NASDAQ:VERU) - MarketBeat
NewEdge Advisors LLC Raises Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World
Check out these key findings about Veru Inc (VERU) - Sete News
Veru Inc (VERU)’s stock price range in the last year - uspostnews.com
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8 - The Manila Times
Veru Inc. to Host Conference Call for Fiscal Q2 2025 Financial Results and Business Update on May 8, 2025 - Nasdaq
B. Riley Securities gives a Buy recommendation for Veru Inc (VERU) - knoxdaily.com
Veru Inc (VERU) Stock: A Comprehensive 52-Week Review - investchronicle.com
Geode Capital Management LLC Increases Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World
ImmunityBio Inc’s Market Journey: Closing Weak at 2.61, Down -2.97 - DWinneX
Trading Day Review: Capri Holdings Ltd (CPRI) Gains Momentum, Closing at 14.87 - DWinneX
Market Momentum: Coherus Biosciences Inc (CHRS) Registers a 1.98 Increase, Closing at 1.03 - DWinneX
Stock Performance Spotlight: Veru Inc (VERU) Ends the Day at 0.54, Down by -2.02 - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Veru Inc. (VERU) Investigation - ACCESS Newswire
SOBO Shares Experience Surge in Value - knoxdaily.com
Was Veru Inc (VERU)’s session last reading good? - uspostnews.com
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summi - GuruFocus
大文字化:
|
ボリューム (24 時間):